Preliminary consolidated sales results of JSC Olainfarm for November show that company’s sales has reached 6.47 million lats (9.21 million euro), which represents an increase by 7% compared to the same period one year ago. The biggest sales increases have been experienced in The Netherlands, where sales grew by 885%, Lithuania by 102%, Belarus by 93% and Russia by 61%. Major sales markets of JSC Olainfarm in November 2013 were Russia, Ukraine, Latvia and Belarus. Considerable shipments have also been made to Tajikistan and Uzbekistan.
| November 2013, consolidated sales | Share in total sales | Changes to November 2012 |
| Russia | 35% | 61% |
| Ukraine | 29% | -39% |
| Latvia | 18% | 43% |
| Belarus | 6% | 93% |
| Kazakhstan | 3% | 10% |
| The Netherlands | 2% | 885% |
| Tajikistan | 1% | NA |
| Uzbekistan | 1% | NA |
| Moldova | 1% | 54% |
| Lithuania | 1% | 102% |
| Other | 2% | -47% |
| Total | 100% | 7% |
In eleven months of 2013 according to preliminary consolidated results, the total sales of JSC Olainfarm was 50.8 million lats (72.28 million euro), which represents an increase by 8% compared to the same period of 2012. The most rapid sales increases were achieved in The Netherlands, where sales grew by 1953%, Spain, where sales grew by 202% and Belarus, where sales grew by 66%. Major sales markets of JSC Olainfarm in eleven months of 2013 were Russia, Latvia, Ukraine and Belarus.
| 11 months of 2013, consolidated sales | Share in total sales | Changes to 11 months of 2012 |
| Russia | 38% | 18% |
| Latvia | 22% | 34% |
| Ukraine | 12% | -46% |
| Belarus | 8% | 66% |
| Kazakhstan | 4% | 11% |
| UK | 3% | -10% |
| Uzbekistan | 2% | 39% |
| The Netherlands | 1% | 1953% |
| Georgia | 1% | 41% |
| Spain | 1% | 202% |
| Other | 7% | 8% |
| Total | 100% | 8% |
Sales of chain of pharmacies Latvijas aptieka Ltd. in November 2013 were 0.82 million lats (1.17 million euro). 52 pharmacies were operating in November 2013. In eleven months of 2013 sales of Latvijas aptieka Ltd. were 8.62 million lats (12.27 million euro). Sales of Silvanols Ltd. in November 2013 was 0.24 million lats (0.34 million euro).
According to unconsolidated preliminary sales results, sales of JSC Olainfarm in November were 5.65 million lats (8.04 million euro), which represents an increase by 2% compared to the same period one year ago. The most rapid sales increases were achieved in the Netherlands, where sales grew by 885%, Belarus, where sales grew by 93%, Russia, where the sales grew by 61%, Moldova, where sales grew by 54% and Latvia, where sales grew by 43%. Products of JSC Olainfarm worth more than 0.061 million lats (0.087 million euro) have been sold to both Tajikistan and Uzbekistan during November. According to unconsolidated results, the major sales markets of JSC Olainfarm in November 2013 were Russia, Ukraine, Latvia and Belarus. In total in November 2013, the sales have been made to 20 countries in three continents.
| November 2013, unconsolidated sales | Share in total sales | Changes to November 2021 |
| Russia | 40% | 61% |
| Ukraine | 33% | -39% |
| Latvia | 8% | 43% |
| Belarus | 7% | 93% |
| Kazakhstan | 4% | 6% |
| The Netherlands | 3% | 885% |
| Tajikistan | 1% | NA |
| Uzbekistan | 1% | NA |
| Moldova | 1% | 54% |
| Lithuania | 1% | 24% |
| Other | 2% | -68% |
| Total | 100% | 2% |
During eleven months according to preliminary unconsolidated sales results, sales of JSC Olainfarm were 43.61 million lats (62 million euro), which represents an increase by 5% compared to the same period one year ago. During eleven months of this year the most rapid sales increases were achieved in The Netherlands and Spain, where the sales have grown by 1953% and 202% respectively. Comparatively rapid sales increase has also been witnessed during this period in Latvia, where sales grew by 71%, Belarus, where sales have grown by 66%, as well as Georgia and Uzbekistan, where sales grew by 39%. According to preliminary unconsolidated sales results, the major sales markets of JSC Olainfarm in eleven months of 2013 were Russia, Ukraine, Latvia, Belarus, Kazakhstan and the UK. In total during 11 months of 2013 JSC Olainfarm has been selling its products to 36 countries in 5 continents.
| 11 months of 2013, unconsolidated result | Share in total sales | Changes to 11 months of 2012 |
| Russia | 45% | 18% |
| Ukraine | 14% | -46% |
| Latvia | 11% | 71% |
| Belarus | 9% | 66% |
| Kazakhstan | 4% | 11% |
| UK | 4% | -10% |
| Uzbekistan | 2% | 39% |
| The Netherlands | 1% | 1953% |
| Georgia | 1% | 39% |
| Spain | 1% | 202% |
| Other | 7% | -5% |
| Total | 100% | 5% |
Operating plan of JSC Olainfarm provides that unconsolidated sales of the company in 2012 will reach 45.4 million lats (64.6 million euro), while consolidated sales will reach 52.8 million lats (75.1 million euro). According to these preliminary sales figures in eleven months of 2013 96% of both targets have been attained.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv
